DHT Stock Overview
Manufactures, trades in, imports, and exports medicines, chemical raw materials for medicine, medicinal materials, and medical equipment.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Ha Tay Pharmaceutical JSC Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₫71,300.00 |
| 52 Week High | ₫79,700.00 |
| 52 Week Low | ₫18,800.00 |
| Beta | 0.54 |
| 11 Month Change | 37.91% |
| 3 Month Change | 151.94% |
| 1 Year Change | 154.64% |
| 33 Year Change | 324.77% |
| 5 Year Change | 388.12% |
| Change since IPO | 3,307.65% |
Recent News & Updates
Recent updates
Shareholder Returns
| DHT | VN Pharmaceuticals | VN Market | |
|---|---|---|---|
| 7D | 1.6% | -2.7% | -2.9% |
| 1Y | 154.6% | 11.6% | 2.1% |
Return vs Industry: DHT exceeded the VN Pharmaceuticals industry which returned 11.6% over the past year.
Return vs Market: DHT exceeded the VN Market which returned 2.1% over the past year.
Price Volatility
| DHT volatility | |
|---|---|
| DHT Average Weekly Movement | 7.3% |
| Pharmaceuticals Industry Average Movement | 4.8% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in VN Market | 7.9% |
| 10% least volatile stocks in VN Market | 2.8% |
Stable Share Price: DHT's share price has been volatile over the past 3 months.
Volatility Over Time: DHT's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of VN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1965 | n/a | n/a | www.hataphar.com.vn |
Ha Tay Pharmaceutical JSC manufactures, trades in, imports, and exports medicines, chemical raw materials for medicine, medicinal materials, and medical equipment. It offers functional foods and drugs. In addition, the company provides medicinal products manufacturing services; and import-export authorization services, as well as supplies pharmaceutical ingredients for enterprises.
Ha Tay Pharmaceutical JSC Fundamentals Summary
| DHT fundamental statistics | |
|---|---|
| Market cap | ₫5.89t |
| Earnings (TTM) | ₫73.31b |
| Revenue (TTM) | ₫2.01t |
80.1x
P/E Ratio2.9x
P/S RatioIs DHT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DHT income statement (TTM) | |
|---|---|
| Revenue | ₫2.01t |
| Cost of Revenue | ₫1.81t |
| Gross Profit | ₫199.34b |
| Other Expenses | ₫126.03b |
| Earnings | ₫73.31b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 890.28 |
| Gross Margin | 9.94% |
| Net Profit Margin | 3.65% |
| Debt/Equity Ratio | 49.0% |
How did DHT perform over the long term?
See historical performance and comparison